In vivo generation of bone marrow from embryonic stem cells in interspecies chimeras
Year: 2022
Type: article
Abstract: Generation of bone marrow (BM) from embryonic stem cells (ESCs) promises to accelerate the development of future cell therapies for life-threatening disorders. However, such approach is limited by technical challenges to produce a mixture of functional BM progenitor cells able to replace all hematopoietic cell lineages. Herein, we used blastocyst complementation to simultaneously produce BM cell lineages from mouse ESCs in a rat. Based on fluorescence-activated cell sorting analysis and single-cell RNA sequencing, mouse ESCs differentiated into multiple hematopoietic and stromal cell types that were indistinguishable from normal mouse BM cells based on gene expression signatures and cell surface markers. Receptor–ligand interactions identified Cxcl12-Cxcr4 , Lama2-Itga6 , App-Itga6 , Comp-Cd47 , Col1a1-Cd44 , and App-Il18rap as major signaling pathways between hematopoietic progenitors and stromal cells. Multiple hematopoietic progenitors, including hematopoietic stem cells (HSCs) in mouse–rat chimeras derived more efficiently from mouse ESCs, whereas chondrocytes predominantly derived from rat cells. In the dorsal aorta and fetal liver of mouse–rat chimeras, mouse HSCs emerged and expanded faster compared to endogenous rat cells. Sequential BM transplantation of ESC-derived cells from mouse–rat chimeras rescued lethally irradiated syngeneic mice and demonstrated long-term reconstitution potential of donor HSCs. Altogether, a fully functional BM was generated from mouse ESCs using rat embryos as ‘bioreactors’.
Source: eLife
DOI: 10.7554/elife.74018
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: bone marrow regeneration, embryonic stem cells, interspecies chimeras, blastocyst complementation, hematopoietic stem cells, hematopoietic progenitor cells, stromal cells, cell-to-cell communication, CXCL12/CXCR4 axis, hematopoietic recovery, bone marrow transplantation, chondrocytes, cell therapy
Open Access status: gold
Estimated APC paid: $2,500
Awards: Targeting Foxm1 in pulmonary fibrosis, Molecular Mechanisms Regulated by FOXM1 in Chronic Lung Remodeling, Role of lung endothelial cells during fibrotic lung remodeling, Transcriptional regulation of goblet cell metaplasia, Transcriptional Regulation of Endothelial Cells after Neonatal Lung Injury, Development of novel therapeutic approaches for treatment of Alveolar Capillary Dysplasia, Foxf1 Transcription Factor in Development of Pulmonary Capillaries
OpenAlex ID: W4298087331
